CNN: Moderna applies for FDA authorization of its COVID-19 vaccine
First patient enrolled in UC/UC Health Moderna vaccine trial tells his story
Jarelle Marshall, the first patient administered a dose in the UC/UC Health Moderna COVID-19 vaccine trial was interviewed by CNN about his experience. Marshall received the first dose on August 25, 2020 with a follow up dose about four weeks later.
Jarelle Marshall receives the first dose of the UC/UC Health Moderna COVID-19 vaccine trial. Photo/Colleen Kelley/UC Creative + Brand
When asked by CNN host Don Lemon about what getting a dose was like, Marshall said, "Other than a sore arm I didn't have any really negative side effects. After the second injection, the day after, my temperature rose a couple degrees around 99 for about a day which made me a little nervous. I was checking my temperature every hour or two. But after that, you know, I was fine. I didn't get sick or didn't have any problems."
Marshall also said that one of the reasons he volunteered for the trial was to set an example for his son.
"I always tell my son, what really matters is what you do when people aren't looking."
Watch the entire segment here and read more about the UC/UC Health Moderna vaccine trial here.
Lead photo Colleen Kelley/UC Creative + Brand
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's medical, graduate and undergraduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
German TV highlights UC expert's ancient Maya discoveries
March 2, 2026
The German television show 'Unsolved Case' talks to a University of Cincinnati expert about ballcourts used by the ancient Maya for a program examining how people used spheres as both tools and toys.
UC studies supplement, therapy alternatives to treat depression
March 2, 2026
Media outlets including Cleveland.com and Cleveland's WKYC News highlighted a new University of Cincinnati clinical trial funded by an approximately $3.5 million grant from the National Institutes of Health’s National Center for Complementary and Integrative Health to test two new nonpharmacological treatments for teens and young adults with depression.
'Paradigm-shifting' study confirms effectiveness of long-acting HIV treatment
February 26, 2026
The results of a clinical trial involving the University of Cincinnati, recently published in The New England Journal of Medicine, show people failing HIV treatments with oral medications were able to be treated successfully using injections.